Kissling E, et al. Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019. Euro Surveill. 2019 Feb;24(8).
Influenza A(H1N1)pdm09 and A(H3N2) viruses both circulated in Europe in October 2018-January 2019. Interim results from six studies indicate that 2018/19 influenza vaccine effectiveness (VE) estimates among all ages in primary care was 32-43% against influenza A; higher against A(H1N1)pdm09 and lower against A(H3N2). Among hospitalised older adults, VE estimates were 34-38% against influenza A and slightly lower against A(H1N1)pdm09. Influenza vaccination is of continued benefit during the ongoing 2018/19 influenza season.
See Also:
Latest articles in those days:
- Analysis of a diffusive epidemic model with a zero-infection zone 3 minute(s) ago
- Quick detection of H5N1 avian influenza virus by surface enhanced Raman scattering(SERS) using aptamer capture 10 minute(s) ago
- The critical role of RAGE in severe influenza infection: A target for control of inflammatory response in the disease 30 minute(s) ago
- Human infection caused by avian influenza A (H10N5) virus 34 minute(s) ago
- Cross-species spill-over potential of the H9N2 bat influenza A virus 13 hours ago
[Go Top] [Close Window]
